Xenon prevents cellular damage in differentiated PC-12 cells exposed to hypoxia

BMC Neuroscience

Volumn 5, Issue , 2004, Pages

  Petzelt, Christian ^a   Blom, Per ^b   Schmehl, Wolfgang ^b   Müller, Jana ^a   Kox, Wolfgang J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Linde Gas   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CALCIUM ION; DOPAMINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; LACTATE DEHYDROGENASE; NERVE GROWTH FACTOR; SULPIRIDE; VANOXERINE; XENON; 1,2-BIS(2-AMINOPHENOXY)ETHANE-N,N,N',N'-TETRAACETIC ACID; BENZAZEPINE DERIVATIVE; CALCIUM; CHELATING AGENT; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; DRUG DERIVATIVE; EGTAZIC ACID; NEUROPROTECTIVE AGENT; PIPERAZINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DAMAGE; CELL DIFFERENTIATION; CELL HYPOXIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; NEUROPROTECTION; NONHUMAN; PHEOCHROMOCYTOMA CELL; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL EMBRYO; ANOXIA; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; MESENCEPHALON; METABOLISM; NERVE CELL; PC12 CELL;

ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; BENZAZEPINES; CALCIUM; CELLS, CULTURED; CHELATING AGENTS; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; EGTAZIC ACID; EMBRYO, MAMMALIAN; L-LACTATE DEHYDROGENASE; MESENCEPHALON; NERVE GROWTH FACTOR; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; PIPERAZINES; RATS; SULPIRIDE; XENON;

EID: 12944335014     PISSN: 14712202     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2202-5-55     Document Type: Article

References (26)

1. Lipton P: Ischemic cell death in brain neurons. Physiol Rev 1999, 79:431-1568.
2. Dirnagl U, Iadekola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397.
3. Akiyama Y, Ito A, Koshimura K, Ohue T, Yamagata S, Miwa S, Kikuchi H: Effects of transient forebrain ischemia and reperfusion on function of dopaminergic neurons and dopamine reuptake in vivo in rat striatum. Brain Res 1991, 561:120-127.
4. Pastuszko A: Metabolic responses of the dopaminergic system during hypoxia in newborn brain. Biochem Med Metab Biol 1994, 51:1-15.
5. Gross J, Ungethum U, Andreeva N, Heldt J, Gao J, Marschhausen G, Altmann T, Muller I, Husemann B, Andersson K: Hypoxia during early developmental period induces long-term changes in the dopamine content and release in a mesencephalic cell culture. Neuroscience 1999, 92:699-704.
6. Kuo JS, Cheng FC, Shen CC, Ou HC, Wu TF, Huang HM: Differential alteration of catecholamine release during chemical hypoxia is correlated with cell toxicity and is blocked by protein kinase C inhibitors in PC12 cells. J Cell Biochem 2000, 79:191-201.
7. Obrenovitch TP, Richards DA: Extracellular neurotransmitter changes in cerebral ischaemia. Cerebrovasc Brain Metab Rev 1995, 7:1-54.
8. Obrenovitch TP: High extracellular glutamate and neuronal death in neurological disorders. Cause, contribution or consequence? Ann N Y Acad Sci 1999, 890:273-286.
9. Greene LA, Tischler AS: PC12 pheochromocytoma cell cultures in neurobiological research. Adv Cell Neurobiol 1982, 3:373-414.
10. Zachor DA, Moore JF, Brezausek C, Theibert A, Percy AK: Cocaine inhibits NGF-induced PC12 cells differentiation through D(1 -type dopamine receptors. Brain Res 2000, 869:85-97.
11. Kim DK, Natarajan N, Prabhakar NR, Kumar GK: Facilitation of dopamine and acetylcholine release by intermittent hypoxia in PC12 cells: involvement of calcium and reactive oxygen species. J Appl Physiol 2004, 96:1206-1215.
12. Dirnagl U, Simon RP, Hallenbeck JM: Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003, 26: 48-254.
13. Petzelt C: New concepts in neuroprotection. J Anästhes Intensivbeh 2001, 3:38.
14. Petzelt C, Blom P, Schmehl W, Müller J, Kox WJ: Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci 2003, 72:1909-1918.
15. Ma D, Wilhelm S, Maze M, Franks NP: Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br J Anaesth 2002, 89:739-746.
16. Wilhelm SW, Daqing M, Maze M, Franks NP: Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 2002, 9:1485-1491.
17. Choi DW, Maulucci-Gedde M, Kriegstein AR: Glutamate neurotoxicity in cortical cell culture. J Neurosci 1987, 7: 57-368.
18. 2+-regulated transitions in the cell cycle of human endothelial cells. PFlugers Arch 1999, 437: 37-744.
19. 2+-calmodulin-activated kinase in the control of metaphase-anaphase transition in human cells. Cell Biol Int 2001, 25:403-409.
20. Uchikawa T, Kiuchi Y, Yura A, Nakachi N, Yamazaki Y, Yokomizo C, Oguchi K: Ca(2+)-dependent enhancement of [3H]dopamine uptake in rat striatum: possible involvement of calmodulin-dependent kinases. J Neurochem 1995, 65:2065-2071.
21. Uchida J, Kiuchi Y, Ohno M, Yura A, Oguchi K: Ca(2+)-dependent enhancement of [(3)H]noradrenaline uptake in PC12 cells through calmodulin-dependent kinases. Brain Res 1998, 809: 55-164.
22. Fu XZ, Zhang QG, Meng FJ, Zhang GY: NMDA receptor-mediated immediate Ser831 phosphorylation of GluR1 through CaMKIIalpha in rat hippocampus during early global ischemia. Neurosci Res 2004, 48:85-91.
23. Parnas H, Segel L, Dudel J, Parnas I: Autoreceptors, membrane potential and the regulation of transmitter release. Trends Neurosci 2000, 23:60-68.
24. Erdemli G, Crunelli V: Release of monoamines and nitric oxide is involved in the modulation of hyperpolarization-activated inward current during acute thalamic hypoxia. Neuroscience 2000, 96: 65-574.
25. Yao R, Yoshihara M, Osada H: Specific activation of a c-Jun NH-2-terminal kinase isoform and induction of neurite outgrowth in PC-12 cells by staurosporine. J Biol Chem 1997, 272: 8261-18266.
26. Andreeva N, Ungethüm U, Heldt J, Marschhausen G, Altmann Th, Andersson K, Gross J: Elevated potassium enhances glutamate vulnerability of dopaminergic neurons developing in mesencephalic cell cultures. Exp Neurol 1996, 137:255-262.